STOCK TITAN

Transactions of Managers and Closely Associated Persons

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Alvogen Lux Holdings S.ár.l., Alvotech's second-largest shareholder, has acquired 95,000 shares of Alvotech (ALVO) at ISK 1,260 per share on May 20, 2025. The transaction was reported to the Luxembourg Commission de Surveillance du Secteur Financier (CSSF). Alvogen Lux Holdings' ownership structure consists of CVC (40%), Aztiq (30%), and Temasek (20%) as its largest shareholders.

Alvogen Lux Holdings S.ár.l., il secondo azionista più grande di Alvotech, ha acquisito 95.000 azioni di Alvotech (ALVO) al prezzo di ISK 1.260 per azione il 20 maggio 2025. L'operazione è stata comunicata alla Commission de Surveillance du Secteur Financier (CSSF) del Lussemburgo. La struttura proprietaria di Alvogen Lux Holdings comprende come maggiori azionisti CVC (40%), Aztiq (30%) e Temasek (20%).

Alvogen Lux Holdings S.ár.l., el segundo mayor accionista de Alvotech, adquirió 95,000 acciones de Alvotech (ALVO) a ISK 1,260 por acción el 20 de mayo de 2025. La transacción fue reportada a la Comisión de Supervisión del Sector Financiero de Luxemburgo (CSSF). La estructura accionarial de Alvogen Lux Holdings está compuesta por los mayores accionistas CVC (40%), Aztiq (30%) y Temasek (20%).

Alvogen Lux Holdings S.ár.l.는 Alvotech의 두 번째로 큰 주주로서, 2025년 5월 20일에 주당 ISK 1,26095,000주를 매입했습니다. 이 거래는 룩셈부르크 금융감독위원회(CSSF)에 신고되었습니다. Alvogen Lux Holdings의 소유 구조는 주요 주주로 CVC (40%), Aztiq (30%), Temasek (20%)로 구성되어 있습니다.

Alvogen Lux Holdings S.ár.l., le deuxième plus grand actionnaire d'Alvotech, a acquis 95 000 actions d'Alvotech (ALVO) au prix de ISK 1 260 par action le 20 mai 2025. La transaction a été déclarée à la Commission de Surveillance du Secteur Financier (CSSF) du Luxembourg. La structure actionnariale d'Alvogen Lux Holdings comprend comme principaux actionnaires CVC (40%), Aztiq (30%) et Temasek (20%).

Alvogen Lux Holdings S.ár.l., der zweitgrößte Aktionär von Alvotech, hat am 20. Mai 2025 95.000 Aktien von Alvotech (ALVO) zum Preis von ISK 1.260 pro Aktie erworben. Die Transaktion wurde der luxemburgischen Finanzaufsichtsbehörde Commission de Surveillance du Secteur Financier (CSSF) gemeldet. Die Eigentümerstruktur von Alvogen Lux Holdings besteht aus den größten Aktionären CVC (40%), Aztiq (30%) und Temasek (20%).

Positive
  • Second-largest shareholder Alvogen Lux Holdings increases its stake in Alvotech, showing confidence in the company
  • Transaction value represents approximately ISK 119.7 million investment in Alvotech shares
Negative
  • None.

Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 95,000 shares in Alvotech at ISK 1,260 per share, by Alvogen Lux Holdings S.ár.l., the second largest shareholder in Alvotech. The date of the transaction is May 20, 2025. Alvogen Lux Holdings' largest shareholders are CVC (40%), Aztiq (30%) and Temasek (20%).

Attachment


FAQ

How many Alvotech (ALVO) shares did Alvogen Lux Holdings purchase on May 20, 2025?

Alvogen Lux Holdings purchased 95,000 shares of Alvotech at ISK 1,260 per share on May 20, 2025.

Who are the largest shareholders of Alvogen Lux Holdings?

Alvogen Lux Holdings' largest shareholders are CVC (40%), Aztiq (30%), and Temasek (20%).

What was the price per share paid by Alvogen Lux Holdings for ALVO stock?

Alvogen Lux Holdings paid ISK 1,260 per share for Alvotech stock.

What is Alvogen Lux Holdings' position among Alvotech shareholders?

Alvogen Lux Holdings is the second-largest shareholder in Alvotech.
Alvotech

NASDAQ:ALVO

ALVO Rankings

ALVO Latest News

ALVO Stock Data

3.16B
72.97M
64.88%
6.26%
0.17%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Luxembourg
Luxembourg